5 results
8-K
EX-99.2
TMCI
Treace Medical Concepts Inc
27 Feb 24
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
4:13pm
on Pathway Towards Sustainable Profitability¹ Jen Lapiplasty® patient
Full-Year 2024 Guidance 16 Guidance range communicated on 2/27/2024. The fact … Differentiated technology and innovative procedures backed by compelling clinical evidence Positioned to deliver sustainable, strong ~20%+ revenue growth
8-K
EX-99.1
TMCI
Treace Medical Concepts Inc
9 Jan 24
Regulation FD Disclosure
6:19pm
access to liquidity, including debt facility, is ~$185 million Solidly on Pathway Towards Sustainable Profitability¹ Jen Lapiplasty® patient
Solid footing … , setting the pace Differentiated technology and innovative procedures backed by compelling clinical evidence Positioned to deliver sustainable
424B4
TMCI
Treace Medical Concepts Inc
26 Apr 21
Prospectus supplement with pricing info
4:14pm
risk unique to the subject cash flows. Finally, an assumption is made regarding the sustainable long-term rate of growth and a residual value
S-1/A
TMCI
Treace Medical Concepts Inc
19 Apr 21
IPO registration (amended)
6:12am
to the subject cash flows. Finally, an assumption is made regarding the sustainable long-term rate of growth and a residual value is estimated and discounted
S-1
TMCI
Treace Medical Concepts Inc
30 Mar 21
IPO registration
12:00am
-average cost of capital, as well as any risk unique to the subject cash flows. Finally, an assumption is made regarding the sustainable long-term rate
- Prev
- 1
- Next